<DOC>
	<DOCNO>NCT01992029</DOCNO>
	<brief_summary>The principal goal demonstrate specific pattern microRNA ( miRNA ) expression correlate definite diagnostic Amyotrophic Lateral Sclerosis ( ALS ) . The investigator use biological sample ( muscle biopsy , Cerebrospinal Fluid ( CSF ) blood sample ) collect three control population : definite ALS patient accord El Escorial diagnostic criterion , control patient without neurological disease orthopedic surgery shoulder disease , control patient explore peripheral neuropathy myopathy . A second goal correlate miRNA pattern severity and/or progression rate motor neuron define progression rate Amyotrophic Lateral Sclerosis Functional Rating Scale ( ALSFRS ) score/year .</brief_summary>
	<brief_title>Study miRNA Expression Pattern Diagnostic Prognostic Biomarker Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Amyotrophic Lateral Sclerosis adult-onset neuro degenerative disease lead muscle wasting , palsy death due respiratory failure within 3 5 year . The effective drug ( Riluzole ) increase life expectancy three month , know average , diagnostic give delay one year France . The identification new biomarkers early diagnostic therefore fundamental importance . This could improve treatment efficacy also give important clue prognostic , rate evolution overall help identify new target future therapeutic . The investigator ' goal find specific miRNA pattern expression associate ALS human use pattern diagnostic prognostic tool . miRNA non-coding small fragment RNA bind mRNA regulate expression . In human , around 700 miRNA far identify . The role miRNA human pathology well establish various type cancer , recent work emphasize role neuro degenerative disease expression profile consider specific Alzheimer , Parkinson Huntington diseases . Very data currently available expression pattern ALS . Previous study however show regulate miRNA spinal cord Moto neuron trigger ALS-like clinical phenotype . A recent work transgenic murine model SOD1 G93A demonstrate role specific miRNA206 regulate re-innervation process neuro-muscular junction . Mi206 ability promote re-innervation process therefore slow disease progression . This research aim study expression 700 miRNA four different group ( 20 patient per group ) : ALS patient , normal control shoulder surgery muscle ( deltoid ) biopsy , patient explore peripheral neuropathy blood sample , lumbar puncture CSF examination neuro-muscular biopsy patient explore myopathy blood sample , lumbar puncture CSF examination muscular biopsy . The ALS group follow every 4 month ALSFRS score blood sample second CSF sample M12 . miRNA pattern expression compare consider significant 2-fold change .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>For ALS patient : Age 45 70 year old Patients definite criterion ALS accord revise El Escorial criterion ( 1998 ) . ALS Patients clinical motor impairment limbs +/ impairment bulbar muscle . Patients clinical motor impairment deltoid muscle ( MRC score &lt; 5 ) For control patient : Age 45 70 year old Patients orthopedic surgery shoulder normal neurological examination Patients peripheral neuropathy motor component need biological blood sample , lumbar puncture CSF examination neuromuscular biopsy complete diagnostic Patients muscular myopathy need biological blood sample deltoid muscle biopsy complete diagnostic . Patients affiliate governmental health plan Clear loyal consent form write sign patient investigator ( exam least day inclusion ) Patients eligible muscle biopsy ( anticoagulation , anti aggregation blood coagulation pathology ) Patients eligible lumbar puncture ( anticoagulation , anti aggregation blood coagulation pathology , recent spine surgery , acquire congenital spine malformation , clinical sign intracranial hypertension , cutaneous infection punction site ) . ALS patient isolate bulbar symptom Patients clinical syndrome ALSplus associate extrapyramidal symptom , cerebellar spinocerebellar syndrome autonomic disorder ocular palsy . Patients mark cognitive impairment ( MMS &lt; 24/30 BREF &lt; 14/18 ) Pregnant breastfeed woman Patients neurological nonneurological disorder interfere ALSFRS score Patients could express consent Patients emergency situation Patients guardianship judicial protection Pace maker , cochlear implant Spinal cord compression trauma Spine surgery Spinal deformity Claustrophobia Metallic foreign body Pregnancy Vital capacity &lt; 50 %</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>ALS</keyword>
	<keyword>miRNA</keyword>
	<keyword>biomarker</keyword>
	<keyword>monocentric observational study</keyword>
</DOC>